The purpose of this research study is to improve cancer care for patients whose treatment outcomes have led to challenges in their quality of life. The study is randomized into 2 groups. Group 1 will receive a pre-rehabilitation referral in addition to their standard of care cancer treatment and Group 2 will resume their standard of care cancer treatment. Regardless of the group you are assigned to, all participants will answer questionnaires at baseline and at their 3-month follow-up.
Thank you for your interest, but this study will start enrolling soon.
North Carolina
Christopher Jensen
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Bladder, Brain and Other Nervous System, Breast, Colorectal, Cervical, Head and Neck, Kidney, Liver, Lung, Melanoma, Pancreatic, Pediatric Cancers, Prostate, Sarcoma (bone and soft tissue), Stomach and Esophageal, Thyroid and Other Gland/Endocrine, Leukemia, Phase 1 Trials (all cancers), Lymphoma, Multiple Myeloma, Uterine (endometrial), Ovarian)
24-1423
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
